0000939767-22-000041.txt : 20220404 0000939767-22-000041.hdr.sgml : 20220404 20220404201106 ACCESSION NUMBER: 0000939767-22-000041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haley Patrick J. CENTRAL INDEX KEY: 0001692954 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 22804807 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_164911744920111.xml FORM 4 X0306 4 2022-03-31 0 0000939767 EXELIXIS, INC. EXEL 0001692954 Haley Patrick J. C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP, Commercial Common Stock 2022-03-31 4 M 0 10000 6.21 A 279191 D Common Stock 2022-03-31 4 S 0 10000 22.43 D 269191 D Common Stock 2022-04-01 4 M 0 10000 6.21 A 279191 D Common Stock 2022-04-01 4 S 0 10000 23 D 269191 D Common Stock 23539 I By spouse Common Stock 10648 I By 401(k) Option (right to buy) 6.21 2022-03-31 4 M 0 10000 0 D 2016-09-16 2022-09-15 Common Stock 10000.0 50000 D Option (right to buy) 6.21 2022-04-01 4 M 0 10000 0 D 2016-09-16 2022-09-15 Common Stock 10000.0 40000 D Includes 175,508 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.32 to $22.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 30, 2022. The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019. /s/ Christopher J. Senner, Attorney in Fact 2022-04-04